• Keirstead is working with human embryonic stem cells to treat spinal cord injury.

    FORBES: Magazine Article

  • And, because of my spinal cord injury from the back breakage, I can't feel my left foot so good either.

    NPR: Craig DeMartino: Winner in the Extremity Games

  • It is an attempt to show the cells and the growth factors they release can help patients with spinal cord injury.

    FORBES: The Scientist Who Helped Stall Stem Cell Research

  • Geron's treatment for spinal cord injury was the first human embryonic stem cell therapy to receive FDA approval for a clinical trial.

    FORBES

  • The lead company developing the cells as treatments, Geron, just recently started the very first trial of embryonic stem cells in humans, to treat spinal cord injury.

    FORBES: How Politics Body Slams Science

  • "The bias has been that people with spinal cord injury don't walk, but a lot of the patients with some movement do" says UCLA neurologist Bruce Dobkin, who led the study.

    FORBES: To Walk Again

  • The work paves the way for stem cells that particularly match the genes of injured patients to be used to treat ailments ranging from diabetes to paralysis due to spinal cord injury.

    FORBES: Cloning's Big Step

  • And Geron of Menlo Park, Calif. is performing animal studies on a variety of different cells derived from human embryonic stem cells, aiming to treat spinal cord injury, heart disease and diabetes.

    FORBES: Magazine Article

  • He has received funding for his lab from Geron, which has an exclusive license of Keirstead's patents and aims to start human trials on spinal cord injury as soon as next year.

    FORBES: Magazine Article

  • Douglas Kerr, a scientist at Johns Hopkins, which is using money from billionaire Bloomberg to create a stem-cell lab, says the lack of NIH help could delay a treatment for spinal cord injury for decades.

    FORBES: Anti-Ban Billionaires

  • This morning, Geron of Menlo Park, for years a leading company in embryonic stem cell research, announced that the first patient had been dosed in a study of its embryonic stem cell treatment for spinal cord injury.

    FORBES: Don't Get Too Excited About The First Embryonic Stem Cell Patient

  • And Geron (nasdaq: GERN - news - people ) of Menlo Park, Calif. is performing animal studies on a variety of different cells derived from human embryonic stem cells, aiming to treat spinal cord injury, heart disease and diabetes.

    FORBES: Despite Bush Veto, Stem Cell Research Abounds

  • Among them are neural cells to treat spinal cord injury and degenerative nervous system diseases, cardiomyocytes to treat heart disease, pancreatic islet cells to treat diabetes, dendritic cells for cancer therapy, chondrocytes for arthritis, osteoblasts to rebuild bone and hepatocytes for drug discovery and liver failure.

    FORBES: Four Standard-Bearers For Stem Cell Therapies

  • Having solved the problem of urination, however, most of those paralysed by spinal-cord injury would like to be able to move again.

    ECONOMIST: We can rebuild him. We have the technology

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定